Recombinant Anti-CD38 x Anti-CD59 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD38 antibody are both extended with the scFv fragment from an anti-CD59 antibody. This BsAb can recruit complement to tumor cells. It is designed for the research of Multiple myeloma (MM); Hematologic malignancies therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY